Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Ariel Denson, PharmD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Srinivasa R. Sanikommu, MD, Nilay A. Shah, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Michael R. Grunwald, MD, Belinda R Avalos, MD, Edward A Copelan, Aleksander L. Chojecki, MD

Blood (2020) 136 (Supplement 1): 14–17.

https://doi.org/10.1182/blood-2020-137250

Published: 2020

Journal Articles

Financial Toxicity Intervention Improves Quality of Life in Hematologic Malignancy Patients

Thomas G. Knight, MD, Melissa Aguiar, MSN, RN, Myra Robinson, MSPH, Allison Martin, PharmD, Heather Cranford, CPhT, Tommy Chen, BS, Rupali Bose, MS, MBA, Jing Ai, MDPhD, Brittany K. Ragon, MD, Aleksander L. Chojecki, MD, Nilay A. Shah, MD, Srinivasa R. Sanikommu, MD, James Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136578

Published: 2020

Journal Articles

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Issam S. Hamadeh, PharmD, Michael R. Grunwald, MD, Allison Martin, PharmD, Jai N. Patel, PharmD, Alexandra Shillingburg, PharmD, Ekaterina Kachur, PharmD, Allene COOK, PharmD, Allison Karabinos, PharmD, Jing Ai, MDPhD, Thomas G. Knight, MD, Brittany K. Ragon, MD, Aleksander L. Chojecki, MD, Nilay A. Shah, MD, Srinivasa R. Sanikommu, MD, Belinda R Avalos, MD, Edward A Copelan, Zainab Shahid, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141124

Published: 2020

Journal Articles

Financial Toxicity Intervention Decreases Mortality in High Risk Hematologic Malignancy Patients

Thomas G. Knight, MD, Melissa Aguiar, MSN, RN, Myra Robinson, MSPH, Allison Martin, PharmD, Tommy Chen, BS, Rupali Bose, MS, MBA, Jing Ai, MDPhD, Brittany K. Ragon, MD, Aleksander L. Chojecki, MD, Nilay A. Shah, MD, Srinivasa R. Sanikommu, MD, James Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137222

Published: 2020

Journal Articles

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Aleksander L. Chojecki, MD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Nicole Cowgill, PharmD, CSP, Srinivasa Reddy Sanikommu, MD, Nilay A. Shah, MD, Charles H. Packman, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Belinda R Avalos, MD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136319

Published: 2020

Journal Articles

Single Unit Red Blood Cell Transfusion Is a Safe and Effective Alternative to Double Unit Transfusion in Hematologic Malignancies

Zelia Bowman, MD, Aaron Cumpston, PharmD, Michael Craig, MD, Sijin Wen, PhD, Peter L. Perrotta, MD, Janice Ahn, MD, Naomi Fei, MD, Nilay A. Shah, MD, Abraham Sebastian Kanate, MD

Blood (2016) 128 (22): 3855.

https://doi.org/10.1182/blood.V128.22.3855.3855

Published: 2016

NARROW

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Financial Toxicity Intervention Improves Quality of Life in Hematologic Malignancy Patients

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Financial Toxicity Intervention Decreases Mortality in High Risk Hematologic Malignancy Patients

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Single Unit Red Blood Cell Transfusion Is a Safe and Effective Alternative to Double Unit Transfusion in Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Financial Toxicity Intervention Improves Quality of Life in Hematologic Malignancy Patients

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Financial Toxicity Intervention Decreases Mortality in High Risk Hematologic Malignancy Patients

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Single Unit Red Blood Cell Transfusion Is a Safe and Effective Alternative to Double Unit Transfusion in Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only